Evidence map›Paper›PMID 37057625›Full record

ArticleCirculation research2023

Enhanced Mitochondria-SR Tethering Triggers Adaptive Cardiac Muscle Remodeling.

Zuzana Nichtová, Celia Fernandez-Sanz, Sergio De La Fuente, Yuexing Yuan, Stephen Hurst, Sebastian Lanvermann, Hui-Ying Tsai, David Weaver, Ariele Baggett, Christopher Thompson and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 4 countries.

Zuzana NichtováMitoCare, Pathology and Genomic Medicine (Z.N., S.H., D.W., A.B., E.L.S., G.C.), Thomas Jefferson University, Philadelphia, PA.
Celia Fernandez-Sanz *Center for Translational Medicine (C.F.-S., S.D.L.F., Y.Y., S.L., H.-Y.T., S.-S.S.), Thomas Jefferson University, Philadelphia, PA.ORCID 0000-0002-3437-7792
Sergio De La Fuente *Center for Translational Medicine (C.F.-S., S.D.L.F., Y.Y., S.L., H.-Y.T., S.-S.S.), Thomas Jefferson University, Philadelphia, PA.
Yuexing YuanCenter for Translational Medicine (C.F.-S., S.D.L.F., Y.Y., S.L., H.-Y.T., S.-S.S.), Thomas Jefferson University, Philadelphia, PA.
Stephen HurstMitoCare, Pathology and Genomic Medicine (Z.N., S.H., D.W., A.B., E.L.S., G.C.), Thomas Jefferson University, Philadelphia, PA.ORCID 0000-0002-9333-4629
Sebastian LanvermannCenter for Translational Medicine (C.F.-S., S.D.L.F., Y.Y., S.L., H.-Y.T., S.-S.S.), Thomas Jefferson University, Philadelphia, PA.
Hui-Ying TsaiCenter for Translational Medicine (C.F.-S., S.D.L.F., Y.Y., S.L., H.-Y.T., S.-S.S.), Thomas Jefferson University, Philadelphia, PA.
David WeaverMitoCare, Pathology and Genomic Medicine (Z.N., S.H., D.W., A.B., E.L.S., G.C.), Thomas Jefferson University, Philadelphia, PA.
Ariele BaggettMitoCare, Pathology and Genomic Medicine (Z.N., S.H., D.W., A.B., E.L.S., G.C.), Thomas Jefferson University, Philadelphia, PA.ORCID 0000-0001-9623-4052
Christopher ThompsonThermo Fisher Scientific, Hillsboro, OR (C.T., C.B.-M.).ORCID 0000-0003-2240-093X
Cedric Bouchet-MarquisThermo Fisher Scientific, Hillsboro, OR (C.T., C.B.-M.).
Péter VárnaiDepartment of Physiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary (P.V.).ORCID 0000-0002-7777-806X
Erin L SeifertMitoCare, Pathology and Genomic Medicine (Z.N., S.H., D.W., A.B., E.L.S., G.C.), Thomas Jefferson University, Philadelphia, PA.
Gerald W DornCenter for Pharmacogenomics, John T. Milliken Department of Medicine, Washington University School of Medicine, St Louis, MO (G.W.D.).ORCID 0000-0002-8995-1624
Shey-Shing SheuCenter for Translational Medicine (C.F.-S., S.D.L.F., Y.Y., S.L., H.-Y.T., S.-S.S.), Thomas Jefferson University, Philadelphia, PA.
György CsordásMitoCare, Pathology and Genomic Medicine (Z.N., S.H., D.W., A.B., E.L.S., G.C.), Thomas Jefferson University, Philadelphia, PA.ORCID 0000-0003-3156-1460
Thomas Jefferson University · USThermo Fisher Scientific (United States) · USSemmelweis University · HUWashington University in St. Louis · US

Funding

THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASER35HL135736 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2017 to 2023
$6.4M
Ca2+ and ROS Crosstalk Signaling in Cardiac MitochondriaR01HL093671 · NHLBI · UNIVERSITY OF ROCHESTER · PI SHEU, SHEY-SHING · 2010 to 2023
$5.1M
Mitochondria-SR Tethering: Its Role in Cardiac Bioenergetics and Ca2+ DynamicsR01HL122124 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI CSORDAS, GYORGY, SHEU, SHEY-SHING · 2014 to 2025
$4.0M
Structural-functional zoning of the mitochondrion in cardiac Ca2+, ROS, and energetics regulationR01HL142864 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI CSORDAS, GYORGY, SHEU, SHEY-SHING · 2018 to 2021
$2.5M
Pathogensis of myopathies caused by novel mitochondrial phosphate carrier mutationsR01GM123771 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI SEIFERT, ERIN · 2017 to 2020
$1.2M
Vevo 3100 ultrasound scanner and PV loop systemS10OD030483 · OD · THOMAS JEFFERSON UNIVERSITY · PI FORSBERG, FLEMMING · 2021 to 2021
$747k
Optimice 100-Cage IVC SystemS15OD039813 · OD · THOMAS JEFFERSON UNIVERSITY · PI LATOURETTE, PHIL · 2025 to 2025
$348k
NHLBI NIH HHS R01 HL093671NHLBI NIH HHS R01 HL122124NHLBI NIH HHS R01 HL142864NHLBI NIH HHS R35 HL135736NIGMS NIH HHS R01 GM123771NIH HHS S10 OD030483NIH HHS S15 OD039813
6 · The paper itself

Abstract

backgroundCardiac contractile function requires high energy from mitochondria, and Ca

methodsWe introduced to mice a cardiac muscle-specific engineered tether (linker) transgene with a fluorescent protein core and deployed 2D/3D electron microscopy, biochemical approaches, fluorescence imaging, in vivo and ex vivo cardiac performance monitoring and stress challenges to characterize the linker phenotype.

resultsExpressed in the mature cardiomyocytes, the linker expanded and tightened individual mitochondria-junctional SR contacts; but also evoked a marked remodeling with large dense mitochondrial clusters that excluded dyads. Yet, excitation-bioenergetics coupling remained well-preserved, likely due to more longitudinal mitochondria-dyad contacts and nanotunnelling between mitochondria exposed to junctional SR and those sealed away from junctional SR. Remarkably, the linker decreased female vulnerability to acute massive β-adrenergic stress. It also reduced myocyte death and mitochondrial calcium-overload-associated myocardial impairment in ex vivo ischemia/reperfusion injury.

conclusionsWe propose that mitochondria-SR/endoplasmic reticulum contacts operate at a structural optimum. Although acute changes in tethering may cause dysfunction, upon chronic enhancement of contacts from early life, adaptive remodeling of the organelles shifts the system to a new, stable structural optimum. This remodeling balances the individually enhanced mitochondrion-junctional SR crosstalk and excitation-bioenergetics coupling, by increasing the connected mitochondrial pool and, presumably, Ca

Indexed as

Calcium SignalingSarcoplasmic ReticulumAnimalsCalciumFemaleMiceMitochondria, HeartMyocardiumMyocytes, CardiacReactive Oxygen SpeciesCalciumReactive Oxygen Speciesischemiamitochondriamuscle cellsmyocardiumreperfusionsarcoplasmic reticulumtransgenes

Identifiers

PMID37057625
PMCPMC10213149
OpenAlexW4365483747

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.